Rothblatt Martine a
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1106578. Latest Form 4 filed Oct 22, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| UNITED THERAPEUTICS CorpUTHR | Chairperson & CEO, Director, Officer | 60 | 2026-10-21 | 2026-10-28 |
Transactions: 60
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-21 | UNITED THERAPEUTICS CorpChairperson & CEO, Director, Officer | Sale | 200 | $561.4429 | $112.3k | Form 4 |
| 2026-10-21 | UNITED THERAPEUTICS CorpChairperson & CEO, Director, Officer | Sale | 820 | $560.4954 | $459.6k | Form 4 |
| 2026-10-21 | UNITED THERAPEUTICS CorpChairperson & CEO, Director, Officer | Sale | 743 | $559.2482 | $415.5k | Form 4 |
| 2026-10-21 | UNITED THERAPEUTICS CorpChairperson & CEO, Director, Officer | Sale | 1,137 | $558.3184 | $634.8k | Form 4 |
| 2026-10-21 | UNITED THERAPEUTICS CorpChairperson & CEO, Director, Officer | Sale | 1,702 | $557.2454 | $948.4k | Form 4 |
| 2026-10-21 | UNITED THERAPEUTICS CorpChairperson & CEO, Director, Officer | Sale | 567 | $556.4129 | $315.5k | Form 4 |
| 2026-10-21 | UNITED THERAPEUTICS CorpChairperson & CEO, Director, Officer | Sale | 550 | $555.1946 | $305.4k | Form 4 |
| 2026-10-21 | UNITED THERAPEUTICS CorpChairperson & CEO, Director, Officer | Sale | 194 | $553.7824 | $107.4k | Form 4 |
| 2026-10-21 | UNITED THERAPEUTICS CorpChairperson & CEO, Director, Officer | Sale | 46 | $552.5241 | $25.4k | Form 4 |
| 2026-10-21 | UNITED THERAPEUTICS CorpChairperson & CEO, Director, Officer | Option exercise | 9,500 | $117.76 | $1.1m | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 01:04 ET. Listed shows no prices and gives no investment advice.